| 2.
by availability of reliable data through patient registers,
standardized banking of patient data and well organised disease
specific parent/patientgroups
3. by promoting and supporting the work of ENMC, WMS, MSM,
IC-NMD, national NMDAs
4. by stimulating and supporting research groups and participation
in trials. . |